baber/WOPTO huggingface dataset:
Patent AT-E126798-T1 (AT)
Inventor: CREMER GERARD
IPC: A61K31/47
Filed: 1992-10-22
Granted: 1995-09-15
Abstract: Compounds corresponding to the formula (I) <IMAGE>  in which,     R1 represents either a 1H-tetrazol-5-yl group or a CO2H group,   R2 represents either a (C1-7)alkyl group or a (C2-6)alkenyl group, R3 and R4 represent, each independently of the other, either a hydrogen atom, or a halogen atom, or a cyano group, or a (C1-7)alkyl group, or a (C3-7)cycloalkyl(C1-4)alkyl group, or an aryl group, or an aryl(C1-4)alkyl group, or an aryl(C2-4)alkenyl group, or a group -(CH2)mCOR5 in which m = 0 to 4 and R5 represents a hydrogen atom, an OH group, a (C1-6)alkoxy group or a group NR7R8, R7 and R8 representing, each independently of the other, a hydrogen atom or a (C1-4)alkyl group, or R3 and R4 represents, each independently of the other, a group -(CH2)n-R6 in which n = 1 to 4 and R6 represents an OH group, a (C1-6)alkoxy group, a (C1-4)alkoxy(C1-4)alkoxy group or a (C3-7)cycloalkyl(C1-4)alkoxy group,  and their pharmaceutically acceptable organic or inorganic salts. Application in therapeutics.
Patent AT-E132573-T1 (AT)
Inventor: LANDSBERG THOMAS J
IPC: E21D21/00
Filed: 1992-08-25
Granted: 1996-01-15
Abstract: An open seam friction rock stabilizer having a compressible body with portions alternately in contact with and not in contact with borehole wall, the contacting portions being separated by an angle between 70 degrees and 150 degrees.
Patent AT-E194977-T1 (AT)
Inventor: ARITA M
IPC: C07D213/75
Filed: 1992-09-04
Granted: 2000-08-15
Abstract: A 4-amino(alkyl)cyclohexane-1-carboxamide compound represented by general formula (I), an isomer thereof, and a pharmaceutically acceptable acid addition salt thereof, wherein each symbol is as defined in the specification. These substances have a remarkable, highly persistent and lowly toxic activity of increasing blood stream in coronary, cerebral, renal and peripheral arteries, and are useful as a potent and persistent hypotensive and a drug for preventing and treating diseases of a cardiovascular system such as coronary, cerebral, renal and peripheral arteries. Furthermore, they are useful as an antasthmatic, because they have activities of inhibiting experimental guinea pig asthma caused by the inhalation of histamine and inhibiting contraction of a specimen of an extirpated guinea pig trachea caused by acetylcholine. <CHEM>
Patent AT-E156134-T1 (AT)
Inventor: BORSOTTI GIAMPIETRO
IPC: C07B61/00
Filed: 1993-05-06
Granted: 1997-08-15
Abstract: A process is disclosed for preparing alkyl polyglucosides of general formula (I), by reacting an alcohol with a reducing sugar or with an equivalent of the latter, in the presence of a binary catalyst formed by a strong organic acid and a weak, also organic, base, having a Ka comprised within the range of from 10<-><8> to 10<-><1>. <IMAGE>
Patent AT-E152351-T1 (AT)
Inventor: BLACK LARRY JOHN
IPC: A61K31/38
Filed: 1993-07-26
Granted: 1997-05-15
Abstract: The use of raloxifene, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for preventing or treating osteoporosis in a postmenopausal woman.
Patent AT-E166707-T1 (AT)
Inventor: WOOD ERIC
IPC: F16L55/16
Filed: 1993-02-12
Granted: 1998-06-15
Abstract: The present invention provides that an assembly can be fed into a pipeline or passageway to which a lining tube is to be applied. The lining is impregnated with curable synthetic resin, and surrounds an inflatable bladder, the bladder in turn surrounding a core pipe through which medium flowing in the pipeline or passageway can pass during the lining operation. The core pipe is of sufficiently rigid nature to withstand an inflation pressure to move the lining tube onto the pipeline or passageway surface by inflation of the bladder, but yet is sufficiently flexible and bendable so as to bend enabling it to follow curves and falls in the pipeline or passageway into which it is inserted. Specifically the tube should be sufficiently bendable to enable the assembly to be fed down a manhole and into the underground pipeline or passageway.
Patent AT-E182509-T1 (AT)
Inventor: FARKAS ROBERT
IPC: B29C44/02
Filed: 1993-03-24
Granted: 1999-08-15
Abstract: A method for the production of moulded articles having a width dimension greater than their thickness, e.g. building panels and doors, comprises charging into a mould a foamable composition containing a phenol-formaldehyde resin, an acid catalyst and a filler having a neutralising effect, causing the composition to expand to fill the mould and the resin to cure, and thereafter removing the moulded article from the mould, wherein the mould cavity has a depth substantially equal to the width of the resulting moulded article and a width substantially equal to the thickness of the resulting moulded article, the temperature of the mould surface at the commencement of charging of the foamable composition is in the range of 60 to 90  DEG C, the temperature of the foamable composition during curing is at least 90  DEG C, and the pH of the final cured foam is not less than 2. The neutralising effect filler is preferably aluminium hydroxide, which allows the pH of the curing/foaming reaction to rise to 2 to 4. The resin may be glycol-modified.
Patent AT-E131843-T1 (AT)
Inventor: WEIDNER RICHARD DR
IPC: C08G77/32
Filed: 1993-05-13
Granted: 1996-01-15
Abstract: PCT No. PCT/EP93/01201 Sec. 371 Date Oct. 12, 1994 Sec. 102(e) Date Oct. 12, 1994 PCT Filed May 13, 1992 PCT Pub. No. WO93/23455 PCT Pub. Date Nov. 25, 1993The present invention relates to a process for the preparation of organopolysiloxane resins by hydrolysis and condensation of silanes and/or (partial) hydrolysates thereof.
Patent AT-E165508-T1 (AT)
Inventor: PREISS DETLEF DR
IPC: A61P31/04
Filed: 1994-11-15
Granted: 1998-05-15
Abstract: This invention relates to the use of 2-methylamino-2-phenylcyclohexanone and of pharmaceuticals which contain this active agent in combination with physiologically acceptable solid or liquid supporting materials or diluents for treating bacterial, fungal, virus or protozoan infections as well as for immunomodulation.
Patent AT-E205460-T1 (AT)
Inventor: KUCZYNSKI KRZYSZTOF
IPC: C02F5/14
Filed: 1994-05-24
Granted: 2001-09-15
Abstract: A process of inhibiting oxalate scale formation in aqueous systems is disclosed. A preferred class of scale inhibitors is represented by polyamino hexamethylene phosphonates. These phosphonate inhibitors can be used in levels of from 0.05 ppm to 300 ppm (of the aqueous solution) at pH in the near neutral to preferably alkaline medium.
Patent AT-E172108-T1 (AT)
Inventor: DILLENBURG HELMUT
IPC: A61K8/30
Filed: 1994-02-11
Granted: 1998-10-15
Abstract: Monocarboxylic acid esters of di- and/or triglycerine are used as active principle against skin impurities and/or propionibacterium acnes. Also disclosed are cosmetic compositions containing an effective amount of monocarboxylic acid esters of di- and/or triglycerine.
Patent AT-E147981-T1 (AT)
Inventor: BOUSSEAU ANNE
IPC: C07D233/26
Filed: 1994-02-25
Granted: 1997-02-15
Abstract: The invention relates to the application of riluzole or the pharmaceutically acceptable salts of this compound in the treatment of neuro-AIDS.
Patent AT-E218354-T1 (AT)
Inventor: OESTERBERG THOMAS
IPC: A61K38/43
Filed: 1994-03-24
Granted: 2002-06-15
Abstract: PCT No. PCT/SE94/00265 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Mar. 24, 1994 PCT Pub. No. WO94/26286 PCT Pub. Date Nov. 24, 1994The present invention relates to a final drug product comprising coagulation factor VIII in an aqueous solution with a reduced concentration of oxygen. In this way, the factor VIII activity can be retained during storage to a surprisingly high degree. The factor VIII activity can be retained for a prolonged period of time, if the final drug product further comprises an inert gas and/or an antioxidant. The present invention also relates to processes for reducing the oxygen concentration of the aqueous solution, and a method for improving the stability of factor VIII in an aqueous solution by storing the solution under an inert gas atmosphere. By the present invention it is possible to retain at least 50% of the initial activity of factor VIII after storage for at least 6 months at a temperature of 2 to 10 DEG  C. and a pH of the solution of 6.5 to 8.5.
Patent AT-E162773-T1 (AT)
Inventor: PEVELING ARTHUR
IPC: B01F7/24
Filed: 1994-08-22
Granted: 1998-02-15
Abstract: A bulk material handling system has a silo (1), a downward tapering, substantially funnel-shaped section (2) at the lower end of the silo (1), a circulating arrangement (10) and a discharging arrangement (9) in communication with the circulating arrangement (10) for discharging the circulating bulk material out of the circulating arrangement (10) and the silo (1). The object of the invention is to create an improved bulk material handling system of the above-mentioned type. For that purpose, a circulating arrangement (10) in the silo (1) takes the bulk materials from a lower area (3) of the silo (1) and conveys them to a higher area of the silo (1), which is located however underneath its maximum filling level. The circulating arrangement (10) has a covering arrangement (15) designed to allow the bulk materials to be discharged through the upper end of the circulating arrangement (10) without being substantially subjected to the pressure of the bulk material inside the silo (1).
Patent AT-E152194-T1 (AT)
Inventor: LEINER LEE H
IPC: D21H19/10
Filed: 1994-08-30
Granted: 1997-05-15
Abstract: An improved method of deacidifying books, imaged paper and other imaged materials having a cellulose base wherein, for a sufficient time to raise the pH of the materials, the materials are treated with alkaline particles of a basic metal oxide, hydroxide or salt dispersed in an inert perflourinated carrier, preferably selected from the group consisting of perfluoropolyoxyether, perfluoromorpholine and combinations thereof. Perfluoropolyoxyether alkanoic acid is added as a surfactant. Alternatively, when perfluoromorpholine is the carrier of choice, the surfactant may instead be potassium fluoroalkyl carboxylate.
Patent AT-E168980-T1 (AT)
Inventor: ROLLICK KEVIN LOUIS
IPC: B01J31/02
Filed: 1994-10-10
Granted: 1998-08-15
Abstract: Technology for recycling polymers, such as polyethylene terephthalate (PET), is increasingly important in reducing the amount of polymeric materials deposited in landfills. The invention employs a base hydrolysis process to depolymerize, e.g. PET, which is improved by the addition of an oxidation step (preferably aeration) to oxidize impurities to highly insoluble impurities which may be removed by filtration, and may be further improved by the use of a quaternary ammonium hydroxide or a nonionic surfactant in the hydrolysis stage.
Patent AT-E208868-T1 (AT)
Inventor: BRENNAN MICHAEL
IPC: B23B41/08
Filed: 1995-09-12
Granted: 2001-11-15
Abstract: The tapping device includes a body that receives a cutter and sleeve. The cutter and sleeve advance together to form an opening in the sidewall of a main conduit about which the body is secured. The sleeve includes external threads that grip into the conduit sidewall. Thereafter, retraction of the cutter leaves the sleeve in place to secure the tapping device to the conduit and establish fluid communication therethrough. The cutter and sleeve preferably have different thread pitches, so that the sleeve advances at a slightly faster rate than the cutter. This facilitates sealing engagement between the external surface of the main conduit and the body. A one-way drive arrangement is provided between the sleeve and cutter so that once the sleeve is positioned in place, the cutter can be removed without altering the location of the sleeve.
Patent AT-E200028-T1 (AT)
Inventor: PETERSON TIMOTHY A
IPC: A61K47/40
Filed: 1994-11-08
Granted: 2001-04-15
Abstract: A transdermal drug delivery device involving a backing bearing at least one adhesive layer of an acrylate copolymer and a therapeutically effective amount of (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole. The device optionally further involves (i) a second adhesive layer of an acrylate copolymer and optionally a therapeutically effective amount of (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole, and (ii) a membrane intermediate the first and second adhesive layers.
Patent AT-E165503-T1 (AT)
Inventor: EUFINGER HARALD
IPC: A61C9/00
Filed: 1994-12-02
Granted: 1998-05-15
Abstract: PCT No. PCT/EP94/04020 Sec. 371 Date Aug. 5, 1996 Sec. 102(e) Date Aug. 5, 1996 PCT Filed Dec. 2, 1994 PCT Pub. No. WO95/15131 PCT Pub. Date Jun. 8, 1995A process for producing endoprosthesis has the data block of a three-dimensional actual model (10) of the existing bone structure of a patient acquired using CT scanning. In a computer the actual model (10) thus determined is subtracted from the data block of an existing or CT scan-generated three-dimensional reference model (14). Then from the difference a computer-internal model for the endoprosthesis is formed. With this process, it is possible to reduce the work required for making the corrective adaptation of the endoprosthesis and to avoid faulty adaptations. The data blocks of the actual model (10) and reference model (14) are converted into the data of a CAD free form surface geometry. This is done by describing the limiting surfaces of the models through Spline and Bezier functions oriented to points of support and are imaged, and superimposed, on the computer monitor. This imaging is used to take back segments of the interface (11) of the actual model (10) by displacing points of support toward the volume of the reference model (14).
Patent AT-E180740-T1 (AT)
Inventor: WALTERS GLENN J
IPC: A23L5/10
Filed: 1995-01-23
Granted: 1999-06-15
Abstract: A conductive structure for use in microwave food packaging which adapts itself to heat food articles in a safer, more uniform manner is disclosed. The structure includes a conductive layer disposed on a non-conductive substrate. Provision in the structure's conductive layer of fuse links and base areas causes microwave induced currents to be channeled through the fuse links, resulting in a controlled heating. When over-exposed to microwave energy, fuses break more readily than the conductive base areas resulting in less absorption of microwave energy in the area of fuse breaks than in other regions where fuses do not break. In this way the fused microwave conductive structure compensates for the uneven microwave field within a microwave oven and at the same time provides a safer conductive structure less likely to overheat. In addition, by varying the dimensions of the fuse links and base areas it is possible to design and fabricate different fused microwave conductive structures having a wide range of heating characteristics. Thus, a fused microwave conductive structure permits food heating temperatures to be tuned for food type.
Patent AT-E188152-T1 (AT)
Inventor: KAMMERMEIER DIRK
IPC: B23B51/02
Filed: 1995-04-27
Granted: 2000-01-15
Abstract: PCT No. PCT/EP95/01600 Sec. 371 Date Oct. 15, 1996 Sec. 102(e) Date Oct. 15, 1996 PCT Filed Apr. 27, 1995 PCT Pub. No. WO95/29030 PCT Pub. Date Nov. 2, 1995A rotary drill comprising a shaft of full carbide metal which shaft is to be connected to the driving spindle of a machine tool. The shaft contains helically extending ducts which run adjacent to one another through the shaft, substantially longitudinally, for transporting cooling fluid to the cutting edge of the drill. At least two of the ducts are covered by a common sealing plate adjacent the cutting end of the shaft, with the sealing plate being a distance from the cutting edges of the drill, to create a closed fluid flow path between the ducts to permit dry operation of the drill.
Patent AT-E212844-T1 (AT)
Inventor: OHSAWA NAKAAKI
IPC: A61K9/08
Filed: 1995-08-07
Granted: 2002-02-15
Abstract: A remedy for myotonic dystrophy, containing dehydroepiandrosterone sulfate or a pharmacologically acceptable salt thereof, being efficacious for myotonia, adynamia and amyotrophy, and having a high safety.
Patent AT-E205884-T1 (AT)
Inventor: TAKACS LASZLO
IPC: C12Q1/37
Filed: 1995-07-13
Granted: 2001-10-15
Abstract: The present invention involves a variety of assay methods and devices for screening or diagnosing the occurrence of extrahepatic biliary atresia. In particular the methods and devices involve an antibody specifically for the detection of dipeptidyl peptidase IV in a test sample as indicative of extrahepatic biliary atresia.
Patent AT-E211399-T1 (AT)
Inventor: JEWETT WARREN R
IPC: A61M11/00
Filed: 1995-11-14
Granted: 2002-01-15
Abstract: A metered dose inhaler is described having an improved electronic counting means to indicate the doses remaining in the aerosol canister component of the inhaler assembly.
Patent AT-E219230-T1 (AT)
Inventor: MAYER GEORG DIPL-ING
IPC: F24F1/00
Filed: 1996-01-24
Granted: 2002-06-15
Abstract: The functions of heating and possibly of ventilation and/or cooling are provided by modular structural units (9,20,21,28,29) adjusted to one another. Subsequent adjustment occurs in stages, starting with the heating function. The heating unit (9) is arranged outside the air current produced for the ventilating and cooling functions. In the heating stage, the heating unit is arranged in the breast area (6) of the window of the room (1) at a distance from the floor, esp. a double floor (8). A free space between the heating unit and the floor is covered with a viewing screen (13).
Patent AT-E203264-T1 (AT)
Inventor: HEFELE JOSEF DR
IPC: B41F15/08
Filed: 1996-03-05
Granted: 2001-08-15
Abstract: A raster-like coating is applied by screen printing to flat flexible material. The web is e.g. a lining for clothing items, the melt adhesive coated as two overlying rasters onto the product. The coating has a base layer unaffected, or only slightly affected by heat, and a melt adhesive layer over it. The latter is more readily affected by heat. In the novel process, the screening stencil (1) perforations are each filled by paste (2) of a soln. or pref. dispersion of the thermally inactive plastic mass. The screen is then brought into contact with the web (3) and the doctor blade (4) adds to the externally coated paste, the melt adhesive (5) paste, which is pressed into the perforations. On removing the coated web structure (8) the resulting double layer is dried and sintered together. Also claimed is the corresponding equipment for the process. Pref. part filling of paste in all perforations, is applied externally to the drum by means of the blade (6), resting on the screen stencil from the outside. The wiping edge is sharply ground and presents an obtuse angle of 120 degrees -150 degrees to the stencil on the paste (2) feeding side. This filling is aided by an internal support (7) reaching over the full width of the screen and resting with its two blades (7a) which conform to the screen inner surface. The base layer paste applied by the outer blade contains polyurethane, polyacrylate, polybutadiene acrylonitrile, polybutadiene-styrene-acrylonitrile or acetate copolymer. The outer coating paste contains a fine grain powder of melt adhesives, PVC, mineral fillers and additionally fatty acid salts, softening agents, thickeners, coagulants, paraffins or waxes. The melt adhesive paste (5) applied by the inner blade is based on copolyamides, copolyesters, low pressure polythene or polyurethane.
Patent AT-E180120-T1 (AT)
Inventor: KUENZEL STEFAN DIPL-ING
IPC: H02P21/00
Filed: 1996-11-04
Granted: 1999-05-15
Abstract: A method for field-oriented control of polyphase machine involves applying a field forming current components (id) via a first current control (1) giving an output voltage component (Ud). A torque-forming component (iq) is then applied via a second current control (2), normal to the direction of flux, to derive an output voltage component (Uq) normal to the flux direction. When the voltage component (Ud) in the flux direction attains a first given voltage threshold value (Udmax), the torque-forming current component is diminished, and when (Uq) attains a second given voltage threshold value (Uqmax) normal to the flux direction, then the field-forming current component (id) is diminished. Using a coordinate transformation (3), the voltages (Ur,Us,Ut) for triggering the rotating field of the machine are generated.
Patent AT-E214145-T1 (AT)
Inventor: MILIANI RACHID
IPC: F25C5/00
Filed: 1996-06-14
Granted: 2002-03-15
Abstract: The present invention relates to a device for dosing and dispensing solid substances such as ice (3), which device is provided with at least one storage chamber (1), at least one discharge opening (8), at least one movable feed element (5) which is arranged between the storage chamber and the discharge opening and has at least one receiving space (7), and means (9) for dosing the quantity of solid substance to be dispensed through the discharge opening. A solid substance such as ice can hereby be dosed and dispensed quickly and hygienically. A suitable choice of the volume of the storage chamber in relation to the adjusted quantity of solid substance for dispensing ensures an uninterrupted operation of the device. <IMAGE>
Patent AT-E253950-T1 (AT)
Inventor: CHEN CHI
IPC: A61B5/00
Filed: 1996-04-17
Granted: 2003-11-15
Abstract: There is disclosed a method and apparatus for automatically conducting peritoneal equilibration testing. The method involves removing a sample of overnight dwell fluid from a patient in an amount sufficient to determine the concentration of a metabolite in the drain fluid. The concentration of the metabolite in the sample is then detected and the overnight dwell fluid is drained and weighed. A known weight of dialysate fluid is instilled into a patient and thereafter there are periodically withdrawn samples of the dialysate fluid and the concentration of metabolite in each sample is determined. The ratio of metabolite concentration of each of the periodically drawn samples to metabolite concentration for the overnight dwell fluid is determined. The patient is then drained after a predetermined dwell time and the volume of drained dialysate is determined. The mass transfer area coefficient of the patient's peritoneal membrane is then obtained as a function of the measured variables. Means are provided for conducting the method for each of the steps described.
Patent AT-E269381-T1 (AT)
Inventor: FEUSTEL DIETER
IPC: C09D11/033
Filed: 1996-04-26
Granted: 2004-07-15
Abstract: Aromatic compound-free solvent for printing inks, consisting of a solvent mixture characterised in that is contains (a) 80-99% by weight aromatic compound-free mineral oil; (b) 1 to 20% by weight of an ester of a C8-C2 fatty acid with up to 60 C atoms in total; and/or (c) 1 to 20% by weight of a fatty alcohol with 6 to 36 C atoms. Also disclosed are printing inks that contain binders, pigments, aromatic compound-free solvents and optional additives.
Patent AT-E238066-T1 (AT)
Inventor: KNOWLES ROBERT W
IPC: A61K39/00
Filed: 1996-05-16
Granted: 2003-05-15
Abstract: The invention provides a method of inducing immunological tolerance and a method of preventing allograft rejection. In both methods, compositions comprising non-depleting anti-CD4 antibody are administered to a primate subject. Compositions comprising non-depleting antibody and eventually donor bone marrow are further disclosed.
Patent AT-E211315-T1 (AT)
Inventor: HO SENG-TIONG
IPC: H01S5/00
Filed: 1996-05-21
Granted: 2002-01-15
Abstract: Laser comprising a first lasing microdisk, microcylinder or microannulus defining a microcavity having a circular cross-sectional periphery and a second waveguiding micromember spaced from the first lasing micromember in a different plane and optically coupled by resonant photon tunneling. The second waveguiding micromember includes a light output coupling for providing light output from the laser without adversely affecting the Q value and low lasing threshold of the microcavity.